Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies.

MLA

Tragiannidis, Athanasios, and Andreas H. Groll. “Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies.” Pediatric Drugs, vol. 23, no. 5, Sept. 2021, pp. 445–55. EBSCOhost, https://doi.org/10.1007/s40272-021-00461-3.

APA

Tragiannidis, A., & Groll, A. H. (2021). Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies. Pediatric Drugs, 23(5), 445–455. https://doi.org/10.1007/s40272-021-00461-3

Chicago

Tragiannidis, Athanasios, and Andreas H. Groll. 2021. “Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies.” Pediatric Drugs 23 (5): 445–55. doi:10.1007/s40272-021-00461-3.